Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Helicobacter pylori | 8 | 2009 | 381 | 1.210 |
Why?
|
| Gastric Mucosa | 7 | 2009 | 598 | 0.820 |
Why?
|
| Interleukin-8 | 11 | 2006 | 689 | 0.580 |
Why?
|
| Antigens, Bacterial | 5 | 2008 | 1170 | 0.520 |
Why?
|
| Transcriptional Activation | 4 | 2007 | 1782 | 0.490 |
Why?
|
| Macrophage Inflammatory Proteins | 4 | 2007 | 122 | 0.480 |
Why?
|
| Chemokines, CC | 4 | 2007 | 291 | 0.440 |
Why?
|
| Stomach | 2 | 2007 | 697 | 0.400 |
Why?
|
| Up-Regulation | 7 | 2008 | 4211 | 0.400 |
Why?
|
| Epithelial Cells | 6 | 2008 | 3678 | 0.390 |
Why?
|
| Bacterial Proteins | 8 | 2009 | 3843 | 0.340 |
Why?
|
| Colon | 5 | 2007 | 1773 | 0.310 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 281 | 0.290 |
Why?
|
| Centaurea | 1 | 2003 | 1 | 0.240 |
Why?
|
| Taraxacum | 1 | 2003 | 1 | 0.240 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2004 | 1284 | 0.230 |
Why?
|
| I-kappa B Proteins | 2 | 2002 | 225 | 0.220 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2003 | 201 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 5 | 2007 | 480 | 0.210 |
Why?
|
| Chemokines, CXC | 3 | 2001 | 422 | 0.210 |
Why?
|
| Muscular Disorders, Atrophic | 1 | 2021 | 33 | 0.190 |
Why?
|
| Activin Receptors, Type I | 1 | 2021 | 142 | 0.190 |
Why?
|
| NF-kappa B | 6 | 2006 | 2500 | 0.180 |
Why?
|
| Activin Receptors, Type II | 1 | 2021 | 127 | 0.180 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1675 | 0.180 |
Why?
|
| Arabidopsis | 1 | 2003 | 459 | 0.180 |
Why?
|
| Intestinal Mucosa | 6 | 2007 | 3038 | 0.170 |
Why?
|
| Glycoproteins | 1 | 2007 | 2260 | 0.170 |
Why?
|
| Fungal Proteins | 1 | 2003 | 912 | 0.170 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2021 | 279 | 0.170 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2021 | 256 | 0.160 |
Why?
|
| Receptors, Chemokine | 3 | 2007 | 669 | 0.150 |
Why?
|
| Metalloproteases | 2 | 2007 | 62 | 0.140 |
Why?
|
| Bacterial Toxins | 7 | 2005 | 933 | 0.130 |
Why?
|
| Enterotoxins | 4 | 2002 | 368 | 0.130 |
Why?
|
| Chemokine CCL20 | 4 | 2007 | 63 | 0.120 |
Why?
|
| Helicobacter Infections | 1 | 1997 | 385 | 0.120 |
Why?
|
| Cell Line | 8 | 2008 | 15994 | 0.110 |
Why?
|
| Transcription, Genetic | 5 | 2002 | 7721 | 0.110 |
Why?
|
| Caco-2 Cells | 4 | 2007 | 387 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2021 | 3770 | 0.100 |
Why?
|
| Receptors, CCR6 | 3 | 2007 | 80 | 0.100 |
Why?
|
| Enterocolitis, Pseudomembranous | 3 | 2005 | 264 | 0.100 |
Why?
|
| Phosphorylation | 4 | 2007 | 8436 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 1421 | 0.090 |
Why?
|
| Gastric Mucins | 1 | 2009 | 20 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2007 | 489 | 0.090 |
Why?
|
| RNA, Messenger | 7 | 2007 | 13029 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2008 | 3862 | 0.080 |
Why?
|
| Interleukin-1 | 4 | 2006 | 1262 | 0.080 |
Why?
|
| Enzyme Activation | 4 | 2004 | 3701 | 0.080 |
Why?
|
| Mucus | 1 | 2009 | 321 | 0.080 |
Why?
|
| Colitis, Ulcerative | 2 | 2002 | 1901 | 0.070 |
Why?
|
| Antitoxins | 2 | 1997 | 82 | 0.070 |
Why?
|
| Saccharomyces | 1 | 2006 | 65 | 0.070 |
Why?
|
| Luciferases, Bacterial | 1 | 2005 | 6 | 0.070 |
Why?
|
| Toxoids | 1 | 2005 | 12 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 4933 | 0.070 |
Why?
|
| Colonic Diseases | 1 | 2007 | 202 | 0.060 |
Why?
|
| Monocytes | 3 | 2000 | 2593 | 0.060 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 451 | 0.060 |
Why?
|
| Chemokine CXCL5 | 3 | 2001 | 27 | 0.060 |
Why?
|
| Cytotoxins | 1 | 2005 | 153 | 0.060 |
Why?
|
| Sp1 Transcription Factor | 2 | 2002 | 144 | 0.060 |
Why?
|
| src-Family Kinases | 1 | 2007 | 551 | 0.060 |
Why?
|
| Neurotensin | 1 | 2004 | 61 | 0.060 |
Why?
|
| Fusarium | 1 | 2003 | 51 | 0.060 |
Why?
|
| Genes, Plant | 1 | 2003 | 124 | 0.060 |
Why?
|
| RNA, Bacterial | 1 | 2005 | 391 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 2505 | 0.050 |
Why?
|
| Bacterial Vaccines | 1 | 2005 | 402 | 0.050 |
Why?
|
| Tyrphostins | 1 | 2001 | 67 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 9410 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 1969 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 1999 | 6313 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2008 | 2751 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2007 | 9274 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2003 | 2049 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2007 | 5180 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2006 | 1051 | 0.040 |
Why?
|
| Cricetulus | 1 | 2021 | 817 | 0.040 |
Why?
|
| Enteritis | 1 | 2000 | 160 | 0.040 |
Why?
|
| Necrosis | 1 | 2003 | 1643 | 0.040 |
Why?
|
| Colitis | 1 | 2007 | 1149 | 0.040 |
Why?
|
| CHO Cells | 1 | 2021 | 1407 | 0.040 |
Why?
|
| Diarrhea | 1 | 2005 | 1343 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2005 | 3001 | 0.040 |
Why?
|
| Neutrophil Activation | 1 | 1997 | 186 | 0.040 |
Why?
|
| Genes, MHC Class I | 1 | 1997 | 258 | 0.040 |
Why?
|
| DNA-Binding Proteins | 4 | 2002 | 9639 | 0.040 |
Why?
|
| Flavonoids | 1 | 1999 | 443 | 0.040 |
Why?
|
| Immunoglobulin G | 3 | 1997 | 4554 | 0.030 |
Why?
|
| Gastrointestinal Transit | 1 | 1997 | 96 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2007 | 2921 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 1998 | 617 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2007 | 23387 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2004 | 4414 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2001 | 1119 | 0.030 |
Why?
|
| Ilium | 1 | 1996 | 155 | 0.030 |
Why?
|
| Quinazolines | 1 | 2001 | 1355 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2002 | 6171 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2007 | 2637 | 0.030 |
Why?
|
| Humans | 22 | 2021 | 742088 | 0.030 |
Why?
|
| Imidazoles | 1 | 1999 | 1205 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1997 | 657 | 0.030 |
Why?
|
| Gene Expression | 1 | 2006 | 7790 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2000 | 1525 | 0.030 |
Why?
|
| DNA Primers | 1 | 1997 | 2892 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2002 | 2924 | 0.030 |
Why?
|
| HT29 Cells | 2 | 2002 | 200 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2007 | 10472 | 0.020 |
Why?
|
| Gene Expression Regulation | 4 | 2002 | 12071 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 1998 | 2211 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 16665 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4553 | 0.020 |
Why?
|
| Urease | 1 | 2009 | 41 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 2126 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2009 | 2552 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2002 | 293 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2009 | 234 | 0.020 |
Why?
|
| Viscosity | 1 | 2009 | 328 | 0.020 |
Why?
|
| Mitochondria | 1 | 2002 | 3520 | 0.020 |
Why?
|
| Crohn Disease | 2 | 2002 | 2301 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 3800 | 0.020 |
Why?
|
| Rheology | 1 | 2009 | 345 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1997 | 2968 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9735 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2002 | 2410 | 0.020 |
Why?
|
| Macrophages | 1 | 2002 | 5655 | 0.020 |
Why?
|
| Glycosylation | 2 | 2002 | 1123 | 0.020 |
Why?
|
| Pyridines | 1 | 1999 | 2818 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 6608 | 0.020 |
Why?
|
| Elasticity | 1 | 2009 | 657 | 0.020 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2007 | 68 | 0.020 |
Why?
|
| Urea | 1 | 2009 | 449 | 0.020 |
Why?
|
| Neutrophils | 2 | 2000 | 3711 | 0.020 |
Why?
|
| Macrophage-1 Antigen | 2 | 1997 | 290 | 0.020 |
Why?
|
| Biopsy | 1 | 1997 | 6756 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1997 | 2542 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 498 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2002 | 12164 | 0.020 |
Why?
|
| Culture Media, Conditioned | 2 | 1997 | 533 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2006 | 275 | 0.020 |
Why?
|
| Culture Techniques | 1 | 2005 | 554 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2007 | 867 | 0.020 |
Why?
|
| Solubility | 1 | 2006 | 1083 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11363 | 0.010 |
Why?
|
| Kinetics | 2 | 2004 | 6474 | 0.010 |
Why?
|
| Sp3 Transcription Factor | 1 | 2002 | 29 | 0.010 |
Why?
|
| Binding Sites | 2 | 2002 | 6115 | 0.010 |
Why?
|
| Animals | 7 | 2021 | 168561 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2002 | 326 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 1997 | 1155 | 0.010 |
Why?
|
| Male | 6 | 2021 | 349538 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2699 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18006 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2002 | 318 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 286 | 0.010 |
Why?
|
| Mice | 3 | 2021 | 81045 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2007 | 2557 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 2002 | 5867 | 0.010 |
Why?
|
| Cattle | 2 | 1997 | 3923 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2000 | 77 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 2006 | 19223 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2005 | 1402 | 0.010 |
Why?
|
| Protein Transport | 1 | 2006 | 1988 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2006 | 1355 | 0.010 |
Why?
|
| Luciferases | 1 | 2001 | 733 | 0.010 |
Why?
|
| Middle Aged | 4 | 2008 | 213127 | 0.010 |
Why?
|
| Swine | 1 | 2009 | 5934 | 0.010 |
Why?
|
| Rhodobacter sphaeroides | 1 | 1998 | 13 | 0.010 |
Why?
|
| Lipid A | 1 | 1998 | 67 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3582 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 6382 | 0.010 |
Why?
|
| Neutrophil Infiltration | 1 | 2000 | 390 | 0.010 |
Why?
|
| Tablets, Enteric-Coated | 1 | 1997 | 23 | 0.010 |
Why?
|
| Immune Sera | 1 | 1997 | 641 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2001 | 1547 | 0.010 |
Why?
|
| Zinc | 1 | 2001 | 683 | 0.010 |
Why?
|
| Pepsin A | 1 | 1997 | 71 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 5062 | 0.010 |
Why?
|
| Gastric Acid | 1 | 1997 | 104 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 697 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4322 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2002 | 1887 | 0.010 |
Why?
|
| Female | 5 | 2008 | 379592 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2002 | 2024 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2440 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 2077 | 0.010 |
Why?
|
| Drosophila | 1 | 2001 | 1484 | 0.010 |
Why?
|
| Permeability | 1 | 1996 | 738 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 8333 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1994 | 1581 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1998 | 1423 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 7289 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14720 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 1997 | 2030 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 12797 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 7317 | 0.010 |
Why?
|
| Feces | 1 | 1997 | 1394 | 0.010 |
Why?
|
| Cell Death | 1 | 1996 | 1695 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 18112 | 0.010 |
Why?
|
| Rabbits | 1 | 1996 | 4886 | 0.010 |
Why?
|
| Antibodies | 1 | 1997 | 2459 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1997 | 3913 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 19862 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1994 | 3139 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1996 | 4143 | 0.000 |
Why?
|
| Cell Movement | 1 | 1994 | 5212 | 0.000 |
Why?
|
| Rats | 1 | 1996 | 24265 | 0.000 |
Why?
|
| Aged | 2 | 2005 | 162944 | 0.000 |
Why?
|
| Adult | 2 | 2005 | 213712 | 0.000 |
Why?
|
| Adolescent | 1 | 1997 | 85649 | 0.000 |
Why?
|
Concepts
(214)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_